z-logo
open-access-imgOpen Access
TRIM28 attenuates Bortezomib sensitivity of hepatocellular carcinoma cells through enhanced proteasome expression
Author(s) -
Zhang Jianchao,
Fan Xiaokai,
Liao Lijuan,
Zhu Yan,
Wan Xiaochun,
Rao Hai,
Chen Liang
Publication year - 2022
Publication title -
clinical and translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 1
ISSN - 2001-1326
DOI - 10.1002/ctm2.603
Subject(s) - proteasome , bortezomib , proteasome inhibitor , cancer research , proteostasis , lactacystin , hepatocellular carcinoma , liver cancer , downregulation and upregulation , medicine , biology , chemistry , gene , microbiology and biotechnology , genetics , multiple myeloma

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom